Presentation is loading. Please wait.

Presentation is loading. Please wait.

The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease  Ingram Schulze-Neick,

Similar presentations


Presentation on theme: "The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease  Ingram Schulze-Neick,"— Presentation transcript:

1 The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease  Ingram Schulze-Neick, MD, Jia Li, MD, Jayne A. Reader, Lara Shekerdemian, MD, Andrew N. Redington, MD, Daniel J. Penny, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 124, Issue 3, Pages (September 2002) DOI: /mtc Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

2 Fig. 1 Hemodynamic variables during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study protocol condition is indicated as follows: *P <.05 and **P <.01. NS, Not significant; inhNO, inhaled NO. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

3 Fig. 2 Metabolic variables and derived cardiac output during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study protocol condition is indicated as follows: *P <.05 and **P <.01. NS, Not significant; inhNO, inhaled NO. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

4 Fig. 3 Vascular resistance during the study protocol. All values are displayed as means ± SEM. Statistical significance of the change of a variable in response to the next study protocol condition is indicated as follows: *P <.05 and **P <.01. NS, Not significant; inhNO, inhaled NO. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions

5 Fig. 4 Correlation of plasma endothelin levels and PVR response to ETA blockade. The arterial ET-1 concentration is related to the decrease of PVR in response to BQ123 infusion (r2 = 0.89, P <.05). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /mtc ) Copyright © 2002 American Association for Thoracic Surgery Terms and Conditions


Download ppt "The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease  Ingram Schulze-Neick,"

Similar presentations


Ads by Google